Further evaluation of one-point microcapsule agglutination test for diagnosis of leptospirosis.
A total of 100 serum samples including 22 acute phase sera and 39 paired sera collected from clinically diagnosed cases of leptospirosis in Ming-shan County, Sichuan Province, China were examined by the one-point microcapsule agglutination test (MCAT), which was developed in Japan, and by conventional microscopic agglutination tests (MAT). The one-point MCAT is more reactive to IgM antibody than MAT and is superior in detecting antibodies in the early stages of the disease.
Cui
J J
JJ
Chengdou Institute of Biological Products, China.
Xiao
G X
GX
Chen
T Z
TZ
Zhu
G F
GF
Sato
T
T
Seki
M
M
Kobayashi
S
S
Arimitsu
Y
Y
D000208:Acute Disease; D000372:Agglutination Tests / Q000379:methods*; D000907:Antibodies, Bacterial / Q000097:blood*; D002908:Chronic Disease; D006801:Humans; D007919:Leptospira / Q000276:immunology*; D007922:Leptospirosis / Q000175:diagnosis*; D011933:Reagent Kits, Diagnostic
D000907:Antibodies, Bacterial; D011933:Reagent Kits, Diagnostic